Concepedia

Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity

Monika Ermann, Doris Riether, Edward R. Walker, Innocent Mushi, James E. Jenkins, Beatriz Noya-Marino, Mark L. Brewer, Malcolm G. Taylor, Patricia Amouzegh, Stephen P. East,

Bioorganic & Medicinal Chemistry Letters · 2008 · 30 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Molecular characterization of a peripheral receptor for cannabinoids

Sean Munro, Kerrie L. Thomas, Muna Abu-Shaar · Nature · 1993 · 5.1K citations

, , +14

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Kenneth J. Valenzano, Laykea Tafesse, Gary Lee et al. · Neuropharmacology · 2005 · 285 citations

, , +13

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

J. Ludovic Croxford, Stephen D. Miller · Journal of Clinical Investigation · 2003 · 177 citations · Full text

, , +17

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

J. Ludovic Croxford, Stephen D. Miller · Journal of Clinical Investigation · 2003 · 160 citations · Full text

, , +17

<i>In vitro</i>and<i>in vivo</i>characterization of A‐796260: a selective cannabinoid CB<sub>2</sub>receptor agonist exhibiting analgesic activity in rodent pain models

B. B. Yao, Gin C. Hsieh, Jennifer M. Frost et al. · British Journal of Pharmacology · 2007 · 136 citations · Full text

, , +17